COVID-19 and NSAIDS: A Narrative Review of Knowns and Unknowns

Concern about the appropriate role of nonsteroidal anti-inflammatory drugs (NSAIDs) in COVID-19 speculate that NSAIDs, in particular ibuprofen, may upregulate the entry point for the virus, the angiotensin-converting enzyme (ACE) 2 receptors and increase susceptibility to the virus or worsen symptom...

Descripción completa

Detalles Bibliográficos
Autores principales: Pergolizzi, Joseph V., Varrassi, Giustino, Magnusson, Peter, LeQuang, Jo Ann, Paladini, Antonella, Taylor, Robert, Wollmuth, Charles, Breve, Frank, Christo, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245573/
https://www.ncbi.nlm.nih.gov/pubmed/32447629
http://dx.doi.org/10.1007/s40122-020-00173-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245573/
https://www.ncbi.nlm.nih.gov/pubmed/32447629
http://dx.doi.org/10.1007/s40122-020-00173-5

Ejemplares similares